E Europe Ltd 13D and 13G filings for NeuroSense Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-15 3:32 pm Sale | 2022-01-11 | 13G | NeuroSense Therapeutics Ltd. NRSN | E Europe Ltd | 0 0.000% | -602,502 (Position Closed) | Filing |
| 2021-12-30 11:13 am Purchase | 2021-12-13 | 13G | NeuroSense Therapeutics Ltd. NRSN | E Europe Ltd | 602,502 5.510% | 602,502 (New Position) | Filing |